These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25612993)

  • 1. [Ipilimumab treatment of metastatic melanoma].
    Ghasemi H; Schmidt H; Stolle LB
    Ugeskr Laeger; 2015 Jan; 177(2A):108-9. PubMed ID: 25612993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.
    Graziani G; Tentori L; Navarra P
    Pharmacol Res; 2012 Jan; 65(1):9-22. PubMed ID: 21930211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune checkpoint antibodies increase survival in patients with metastatic melanoma].
    Fløe LE; Svane IM; Bastholt L; Schmidt H
    Ugeskr Laeger; 2016 Aug; 178(33):. PubMed ID: 27550784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab in the treatment of metastatic melanoma: a summary of recent studies.
    Ascierto PA
    Tumori; 2013; 99(6):302e-5e. PubMed ID: 24503809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases.
    Libon F; Arrese JE; Rorive A; Nikkels AF
    Clin Exp Dermatol; 2013 Apr; 38(3):276-9. PubMed ID: 23020081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipilimumab approved for metastatic melanoma.
    Traynor K
    Am J Health Syst Pharm; 2011 May; 68(9):768. PubMed ID: 21515855
    [No Abstract]   [Full Text] [Related]  

  • 7. Ipilimumab in the treatment of melanoma.
    Trinh VA; Hwu WJ
    Expert Opin Biol Ther; 2012 Jun; 12(6):773-82. PubMed ID: 22500861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ipilimumab lesson in melanoma: achieving long-term survival.
    Delyon J; Maio M; Lebbé C
    Semin Oncol; 2015 Jun; 42(3):387-401. PubMed ID: 25965357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.
    Schartz NE; Farges C; Madelaine I; Bruzzoni H; Calvo F; Hoos A; Lebbé C
    Melanoma Res; 2010 Jun; 20(3):247-50. PubMed ID: 20216240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipilimumab: attenuation of an inhibitory immune checkpoint improves survival in metastatic melanoma.
    Peggs KS; Quezada SA
    Expert Rev Anticancer Ther; 2010 Nov; 10(11):1697-701. PubMed ID: 21080797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of ipilimumab and its role in the treatment of metastatic melanoma.
    Patel SP; Woodman SE
    Drug Des Devel Ther; 2011; 5():489-95. PubMed ID: 22267918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
    Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
    Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial.
    Weber JS; Amin A; Minor D; Siegel J; Berman D; O'Day SJ
    Melanoma Res; 2011 Dec; 21(6):530-4. PubMed ID: 22051508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment possibilities of ipilimumab-induced thrombocytopenia--case study and literature review.
    Kopecký J; Trojanová P; Kubeček O; Kopecký O
    Jpn J Clin Oncol; 2015 Apr; 45(4):381-4. PubMed ID: 25583422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.
    Pintova S; Sidhu H; Friedlander PA; Holcombe RF
    Melanoma Res; 2013 Dec; 23(6):498-501. PubMed ID: 24113862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic malignant melanoma. Successfull treatment with ipilimumab].
    Jansen T; Bruch-Gerharz D; Reifenberger J; Schulte KW
    Hautarzt; 2013 Apr; 64(4):228, 230-1. PubMed ID: 23576166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Anti-PD-1 Antibody Treatment in a Metastatic Melanoma Patient With Known Severe Autoimmune Disease.
    Maul LV; Weichenthal M; Kähler KC; Hauschild A
    J Immunother; 2016 May; 39(4):188-90. PubMed ID: 27023060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.
    Thompson JA; Hamid O; Minor D; Amin A; Ron IG; Ridolfi R; Assi H; Berman D; Siegel J; Weber JS
    J Immunother; 2012 Jan; 35(1):73-7. PubMed ID: 22130164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipilimumab in advanced melanoma: reports of long-lasting responses.
    Farolfi A; Ridolfi L; Guidoboni M; Nicoletti SV; Piciucchi S; Valmorri L; Costantini M; Scarpi E; Amadori D; Ridolfi R
    Melanoma Res; 2012 Jun; 22(3):263-70. PubMed ID: 22516968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.